Richter-like transformation of CLL/SLL after a temporary hold of ibrutinib: A case report
Bruton tyrosine kinase (BTK) inhibitors are used to treat chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), providing survival benefits over traditional chemoimmunotherapy. Richter transformation is the transformation of CLL/SLL into an aggressive lymphoma, typically necessitating a...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2026-01-01
|
| Sarja: | Leukemia Research Reports |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S221304892600018X |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|